HIV Management

Resource Center

Resources
Research Summaries FDA Alerts From the Journal
Insights
Commentary Podcasts Q&As
Interactive
Polls Quizzes
Events & Education
Infectious Diseases Society of America’s IDWeek
Conference on Retroviruses and Opportunistic Infections

Featured

Research Summary
Pills spilling out of bottle
Research Summary
Bictegravir–Lenacapavir Switch Maintains Viral Suppression in HIV-1, Phase 3 Trial Finds
06/09/2026
Ashton L. Stahl
A phase 3 trial found that switching from bictegravir–emtricitabine–tenofovir alafenamide to once-daily bictegravir–lenacapavir maintained viral suppression in adults with HIV-1.
06/09/2026
Pop Quiz
clinician wearing trans flag pin
Pop Quiz
Transgender Patients Face Barriers to HIV Care
06/09/2026
Kate Young
A recent study linked gender-affirming hormone therapy with improved HIV outcomes in transgender populations Do you know what the barriers are to HIV care for transgender individuals? Take the quiz to test...
06/09/2026
FDA Approval
taking a pill
FDA Approval
Doravirine/Islatravir (IDVYNSO) FDA Approval for Virologically Suppressed HIV-1 In Adults
05/13/2026
Anthony Calabro, MA
The FDA approved a once-daily, 2-drug oral regimen for adults with virologically suppressed HIV-1 to replace existing antiretroviral therapy.
05/13/2026

Interactive Features

Pop Quiz
clinician wearing trans flag pin
Pop Quiz
Transgender Patients Face Barriers to HIV Care
06/09/2026
Kate Young
A recent study linked gender-affirming hormone therapy with improved HIV outcomes in transgender populations Do you know what the barriers are to HIV care for transgender individuals? Take the quiz to test...
06/09/2026
Pop Quiz
doctor with patient
Pop Quiz
Population-Level Impact of PrEP Coverage on HIV Diagnoses in the United States
11/13/2025
Anthony Calabro, MA
A recent ecological analysis assessed US state-level data over a decade to determine whether higher pre-exposure prophylaxis (PrEP) coverage correlates with reduced HIV diagnoses. The findings could provide...
11/13/2025
3-in-30
physician taking notes
3-in-30
HIV Screening and Risk Profiles
09/23/2025
Anthony Calabro, MA
Clinical guidelines emphasize both universal and risk-based strategies for HIV screening. Test your understanding of the core concepts in this focused, evidence-based 3-in-30 quiz.
09/23/2025
Pop Quiz
charts
Pop Quiz
Trends in PrEP Coverage, HIV Diagnoses in the United States, 2012–2022
08/12/2025
Anthony Calabro, MA
Over the past decade, pre-exposure prophylaxis (PrEP) has become a key component of HIV prevention in clinical practice. Test your knowledge of how national trends in PrEP uptake have correlated with...
08/12/2025
Pop Quiz
man looking out
Pop Quiz
How Does Social Isolation Impact Disease Management in Adults Aged 50 Years and Older with HIV?
07/28/2025
A review found that loneliness and social isolation can affect behaviors such as medication adherence and health care engagement in adults aged 50 years and older living with HIV.
07/28/2025

Clinical Insights

Multidisciplinary Roundtable
Jeffrey Kwong, DNP, MPH, ANP-BC
Multidisciplinary Roundtable
Hot Topics in HIV Comorbidities and Treatment
02/12/2025
In this multidisciplinary video roundtable discussion, Jeffrey Kwong, DNP, MPH, ANP-BC, interviews pharmacist Milena Murrah, PharmD, MS, psychologist David Vance, PhD, MGS, MS, and internist Jonathan...
02/12/2025
Video: Multidisciplinary Roundtable
Jeffrey Kwong, DNP, MPH, ANP-BC
Video: Multidisciplinary Roundtable
The Multidisciplinary Approach to Managing People With HIV
01/15/2025
In this multidisciplinary video roundtable discussion, Jeffrey Kwong, DNP, MPH, ANP-BC, interviews pharmacist Milena Murray, PharmD, MS, psychologist David Vance, PhD, MGS, MS, and internist Jonathan...
01/15/2025
expert Q&A
margaret lampe
expert Q&A
Achieving Perinatal HIV Elimination Goals
08/12/2024
Margaret A. Lampe, RN, MPH
In this expert Q&A, Margaret A. Lampe, RN, MsC, discusses the elimination of perinatal HIV transmission, elimination goals set out by the CDC, next steps for research, and more.
08/12/2024
conference coverage
dr rolle
conference coverage
Efficacy, Safety of Virologically Suppressed Adults With HIV Switching Treatment From B/F/TAF to Dolutegravir/Lamivudine
07/17/2024
Charlotte M. Rolle, MD, MPH
In this podcast, Charlotte M. Rolle, MD, MPH, discusses her team's research that evaluated the efficacy and safety of switching HIV treatment using bictegravir/emtricitabine/tenofovir alafenamide to...
07/17/2024
Podcast
Alan S. Go, MD
Podcast
Heart Failure Risk in Patients With HIV
02/13/2024
In this podcast, Alan S. Go, MD, discusses the results of his recent study, which examined the relationship between HIV, heart failure, and patient demographics.
02/13/2024